Tag: DMD

Dyne’s Investigational DMD Drug DYNE-251 Gets Japan Orphan Drug Status After Strong Trial Data

Dyne Therapeutics Inc. (NASDAQ:DYN) stands out as one of the top stocks priced under $20. On September 29,…